The Gross Margin of Ryvu Therapeutics SA (RVU.WA) is 69.58%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 69.58% |
| 2023-12-31 | 44.80% |
| 2022-12-31 | -1.65% |
| 2021-12-31 | -228.30% |
| 2020-12-31 | 44.00% |
| 2019-12-31 | -237.09% |
| 2018-12-31 | 67.15% |
| 2017-12-31 | 61.61% |
| 2016-12-31 | 72.26% |
| 2015-12-31 | 71.79% |